Wexford Capital’s Hologic HOLX Stock Holding History

Wexford Capital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,200	Closed	-$344K	–	133
2018 Q1	$344K	Buy	+9,200	New	+$372K	0.03%	96

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wexford Capital's HOLX Position: Q2 2018 in Review

Wexford Capital sold out of Hologic (HOLX) in Q2 2018, closing a stake of 9,200 shares — an estimated $344K sold.

Wexford Capital first reported a position in HOLX in Q1 2018 and held it in 1 quarter. The position peaked at $344K in Q1 2018. 450 funds tracked by Wall St. Rank hold HOLX as of Q2 2018.

Wexford Capital reported no remaining Hologic position as of Q2 2018 after selling out during the quarter.
Wexford Capital sold 9,200 Hologic shares in Q2 2018, an estimated $344K.
Wexford Capital first reported a position in Hologic in Q1 2018 and held it in 1 quarter.
Wexford Capital's Hologic position peaked at $344K in Q1 2018.
450 funds tracked by Wall St. Rank held Hologic as of Q2 2018.

Based on Wexford Capital's 13F filing for Q2 2018, filed 13 Aug 2018.